- Home
- ZGN vs SYRE Comparison
ZGN vs SYRE Comparison
Compare ZGN & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZGN | SYRE |
|---|---|---|
| Founded | 1910 | 2013 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.6B |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | ZGN | SYRE |
|---|---|---|
| Price | $10.41 | $33.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | $10.98 | ★ $56.50 |
| AVG Volume (30 Days) | 592.6K | ★ 744.8K |
| Earning Date | 09-05-2025 | 11-04-2025 |
| Dividend Yield | ★ 1.38% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.43 | N/A |
| Revenue | ★ $2,248,050,499.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.08 | N/A |
| P/E Ratio | $23.62 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.05 | $10.91 |
| 52 Week High | $11.00 | $35.31 |
Technical Indicators
Market Signals| Indicator | ZGN | SYRE |
|---|---|---|
| Relative Strength Index (RSI) | 51.86 | 67.99 |
| Support Level | $10.18 | $32.26 |
| Resistance Level | $10.81 | $34.32 |
| Average True Range (ATR) | 0.29 | 1.80 |
| MACD | -0.05 | -0.18 |
| Stochastic Oscillator | 32.39 | 75.80 |
Price Performance
Historical ComparisonAbout ZGN Ermenegildo Zegna N.V.
Ermenegildo Zegna NV designs creates, and distributes luxury menswear and accessories under the Zegna brand, as well as womenswear, menswear, and accessories under the Thom Browne brand. The company operates in three segments: the Zegna segment (comprising three product lines: Zegna Branded Products, Textile, and Third Party Brands); the Thom Browne segment, and the Tom Ford Fashion segment. The company generates the majority of its revenue from the Zegna segment.
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.